- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Perforomist, Foradil, Oxeze Turbuhaler
Synonyms :
formoterol
Class :
Drugs for asthma and COPD & Bronchodilators (Beta2-agonists/ Adrenergic agonists)
Dosage Forms & Strengths
Aerosol, Inhalation:
12 mcg/actuation
6 mcg/actuation
Nebulization solution, Inhalation:
20 mcg/2ml
Capsule, Inhalation:
12 mcg/capsule
Note: For the treatment of asthma generally used in combination with corticosteroids.
Exercised induced:
6
or 12 mcg 15 minutes before exercise as per need (NMT 48 mcg/day)
Initial:
6 - 12
mcg
via dry powder inhaler every 12 hours. (Do not exceed 24 mcg/day)
Maintenance: 1 capsule inhaled every 12 hours. (Do not exceed 2 capsules/day)
chronic obstructive pulmonary disease (COPD)
20
mg
inhaled by nebulizer twice a day
or
1 or 2 capsules inhaled every 12 hours (Do not exceed 4 capsules/day)
Dosage Forms & Strengths
Aerosol, Inhalation:
12 mcg/actuation
6 mcg/actuation
Nebulization solution, Inhalation:
20 mcg/2ml
Capsule, Inhalation:
12 mcg/capsule
Note: For the treatment of asthma generally used in combination with corticosteroids.
Children >6 years and adolescents <16 years:
12 mcg oral inhalation every 12 hours (Do not exceed 24 mcg/day)
Adolescents >17 years:
Moderate cases: 12 mcg oral inhalation every 12 hours
Severe cases: 24 mcg oral inhalation every 12 hours
Refer to the adult dose.
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
It may enhance QTc interval when combined with perphenazine
QTc interval is increased both by lenvatinib and formoterol
may increase the adverse effect of caffeine and caffeine containing products
may increase the arrhythmogenic effect of inhalational anesthetics
may increase the arrhythmogenic effect of inhalational anesthetics
may increase the arrhythmogenic effect of inhalational anesthetics
may increase the arrhythmogenic effect of inhalational anesthetics
may increase the arrhythmogenic effect of inhalational anesthetics
it may decrease the serum potassium levels
may decrease the levels of serum potassium
Frequency defined:
1%-10%
Chest pain (2%)
Anxiety (2%)
Headache
Voice disorder
Diarrhea
Pruritis
Skin rash
Muscle cramps
Tremor
Abdominal pain
Vomiting
Nausea
Fever
<1%:
Angina pectoris
Cardiac arrhythmia
Cough
Dermatitis
Fatigue
Variable blood pressure
Restlessness
Nervousness
Pregnancy consideration: No adverse effects have been reported in the maternal use of beta-2 agonists. formoterol can be used for the management of asthma in pregnant women.
Lactation: Excretion of formoterol in breast milk is not known.
Pregnancy category:
Patient information leaflet
Generic Name: Formoterol
Pronounced: for-mo-te-rol
Why do we use formoterol?
Formoterol is a bronchodilator. It is used to open airways in lung diseases such as asthma and COPD where spasms may cause breathing problems.